Kun-Wei Liu
Overview
Explore the profile of Kun-Wei Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
678
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chang C, Pai K, Huang C, Chou C, Liu K, Lin H
Prog Brain Res
. 2024 Oct;
290:123-139.
PMID: 39448109
This study delves into the application of Brain-Computer Interfaces (BCIs), focusing on exploiting Steady-State Visual Evoked Potentials (SSVEPs) as communication tools for individuals facing mobility impairments. SSVEP-BCI systems can swiftly...
2.
Chang C, Pai K, Huang C, Chou C, Liu K, Lin H
Prog Brain Res
. 2024 Oct;
290:105-121.
PMID: 39448108
The emergence of brain-computer interface (BCI) technology provides enormous potential for human medical and daily applications. Therefore, allowing users to tolerate the visual response of SSVEP for a long time...
3.
Wang J, Merino D, Light N, Murphy B, Wang Y, Guo X, et al.
Cancer Res
. 2019 Mar;
79(9):2208-2219.
PMID: 30885981
Choroid plexus carcinoma (CPC) is a rare brain tumor that occurs most commonly in very young children and has a dismal prognosis despite intensive therapy. Improved outcomes for patients with...
4.
Kahn S, Wang X, Nitta R, Gholamin S, Theruvath J, Hutter G, et al.
Nat Commun
. 2018 Nov;
9(1):4651.
PMID: 30389946
The original version of this Article omitted Suzana A. Kahn, Siddhartha S. Mitra & Samuel H. Cheshier as jointly supervising authors. This has now been corrected in both the PDF...
5.
Kahn S, Wang X, Nitta R, Gholamin S, Theruvath J, Hutter G, et al.
Nat Commun
. 2018 Oct;
9(1):4121.
PMID: 30297829
Medulloblastoma is the most common malignant brain tumor of childhood. Group 3 medulloblastoma, the most aggressive molecular subtype, frequently disseminates through the leptomeningeal cerebral spinal fluid (CSF) spaces in the...
6.
Garzia L, Kijima N, Morrissy A, De Antonellis P, Guerreiro-Stucklin A, Holgado B, et al.
Cell
. 2018 Jun;
173(6):1549.
PMID: 29856958
No abstract available.
7.
Garzia L, Kijima N, Morrissy A, De Antonellis P, Guerreiro-Stucklin A, Holgado B, et al.
Cell
. 2018 Feb;
172(5):1050-1062.e14.
PMID: 29474906
While the preponderance of morbidity and mortality in medulloblastoma patients are due to metastatic disease, most research focuses on the primary tumor due to a dearth of metastatic tissue samples...
8.
Liu K, Pajtler K, Worst B, Pfister S, Wechsler-Reya R
Sci Signal
. 2017 Mar;
10(470).
PMID: 28292958
Brain tumors are among the leading causes of cancer-related deaths in children. Although surgery, aggressive radiation, and chemotherapy have improved outcomes, many patients still die of their disease. Moreover, those...
9.
Pei Y, Liu K, Wang J, Garancher A, Tao R, Esparza L, et al.
Cancer Cell
. 2016 Mar;
29(3):311-323.
PMID: 26977882
Medulloblastoma (MB) is a highly malignant pediatric brain tumor. Despite aggressive therapy, many patients succumb to the disease, and survivors experience severe side effects from treatment. MYC-driven MB has a...
10.
Bandopadhayay P, Bergthold G, Nguyen B, Schubert S, Gholamin S, Tang Y, et al.
Clin Cancer Res
. 2013 Dec;
20(4):912-25.
PMID: 24297863
Purpose: MYC-amplified medulloblastomas are highly lethal tumors. Bromodomain and extraterminal (BET) bromodomain inhibition has recently been shown to suppress MYC-associated transcriptional activity in other cancers. The compound JQ1 inhibits BET...